By Associated Press - Monday, November 9, 2020

WASHINGTON (AP) - U.S. authorizes emergency use of an experimental Eli Lilly antibody treatment to fight mild, moderate COVID-19 cases.

Copyright © 2026 The Washington Times, LLC.

Please read our comment policy before commenting.